United States · 
Who invested in MOMA Therapeutics?
MOMA Therapeutics's investors include Goldman Sachs, Cormorant Asset Management, Invus, Alexandria Venture Investments and Casdin Capital, and 2 more on record.
United States · Series B startup
Who invested in MOMA Therapeutics
Funding summaryUpdated 26 Oct 2026
$150Mraised across 1 round since 2022, from 1 source
- Latest round
- Series B, $150MMay 2022
- Investors
- 7
The rounds
- May 2022
Founders and team
From MOMA Therapeutics's own website: 1 founder, 4 on the team.
Timur YusufzaiFounder
- Asit ParikhChief Executive Officer
- Adam ThomasChief Administrative Officer
- Marc BallasSVP, Head of Clinical Development
- Nazareth MartinezVP, Strategic Finance
Everyone who backed them
Alexandria Venture InvestmentsVC firm1round
Goldman Sachs AssetmanagementVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about MOMA Therapeutics
How much has MOMA Therapeutics raised?
MOMA Therapeutics has raised $150M across 1 round since 2022.
When did MOMA Therapeutics last raise?
MOMA Therapeutics's most recent round was a Series B of $150M in May 2022.
What was MOMA Therapeutics's biggest round?
Its most recent round, $150M in May 2022, is also its largest on record.
Who backed MOMA Therapeutics first?
MOMA Therapeutics's first round on record, in May 2022, was backed by Goldman Sachs, Cormorant Asset Management and Invus and 4 others.
What stage is MOMA Therapeutics at?
MOMA Therapeutics's latest named round is a Series B, in May 2022.
Where is MOMA Therapeutics based?
MOMA Therapeutics is based in the United States.
Companies like MOMA Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.